The National Cancer Registry is an important entity that enables the evaluation of intervention programs and the design of the oncology network:
Since the ICA financed its establishment in the 1960s, there has been productive collaboration between the two, and each year the number of new patients added to the database grows.
This year as well, upon the request of Prof. Tami Shohat, the Director of the Israel Center for Disease Control of the Ministry of Health, the ICA has been assisting in the financing of the post of a quality control supervisor representing the National Cancer Registry, and has been fleshing out this position.